Ned Sharpless on Biotech’s Future, HHS Shifts, and Global Competition | Making Medicine Podcast
This week, John Stanford sits down with Dr. Ned Sharpless - former NCI Director, Acting FDA Commissioner, and now venture capitalist at Jupiter Bio Ventures. From the challenges of biotech funding, regulatory uncertainty, and the Inflation Reduction Act to the rise of China in biotech, IP battles, and the hype around AI, Ned offers candid insights you won’t hear anywhere else.
What do you think about the current funding environment in biotech?
How should the U.S. respond to China’s scientific rise?
📱If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.